{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-022935","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2023-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.901744+00:00","generated_at":"2026-06-13T18:46:33.467806+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"low","headline":"Cumberland settles breach-of-contract suit with Melinta/Targanta, receives undisclosed consideration","bullets":["Settlement finalized June 16, 2023; case closed in NY Supreme Court.","Company had sought $1M in milestone payments for NDA/sNDA filings.","Defendants obtained license to Company patents for product development.","Original action filed Feb 2022; refiled Nov 2022 after jurisdiction change."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-022935","json":"https://secwatch.observer/filing/0001628280-23-022935.json","markdown":"https://secwatch.observer/filing/0001628280-23-022935.md","text":"https://secwatch.observer/filing/0001628280-23-022935.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000162828023022935/0001628280-23-022935-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000162828023022935/cpix-20230616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T18:46:33.467806+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}